跳至主要内容
临床试验/NL-OMON46941
NL-OMON46941招募中2 期

The effects of Vitamin K2 supplementation on the progression of Coronary Artery Calcification - VitaK-CAC

Interne Geneeskunde0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - age 18 years or older
  • - Baseline Coronary Computed Tomographic Angiography (CCTA) of sufficient quality
  • - Baseline Agatston calciumscore 50 - 400

排除标准

  • - Baseline-scan of insufficient quality (due to the presence of motion artefacts, breathing artefacts or high noise-levels)
  • - Heart rate greater than 70 beats per minute during first scan.(despite adequeate treatment with metoprolol)
  • - Chronic or paroxysmal Atrial Fibrillation
  • - Presence or scheduled coronary revascularization procedure (balloon-dilatation or stent-placement in more than one artery or bypass-grafting).
  • - History of myocardial infarction or stroke within the last 6 months before CT-scan.
  • - Presence of Diabetes Mellitus type 1
  • - Known kidney disease or a Glomerular Filtration Rate (GFR) < 60 ml/min/1.73m2 calculated by the MDRD-formula (Levene; 2001).
  • - Malignant disease (exception: treated basal-cell or squamous cell carcinoma).
  • - Use of Vitamin K antagonists.
  • - A life-expectancy < 2 years
  • - Pregnancy or wish to become pregnant in the near future.

研究者

发起方
Interne Geneeskunde

相似试验

The effects of Vitamin K2 supplementation on the... | 临床试验